產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-?BTBD14A抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-?BTBD14A抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-?BTBD14A
Cat. Number:
Anti-?BTBD14A抗體KL-12907R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
BTBD14A is a 587 amino Anti-?BTBD14A抗體acid protein that contains one BTB/POZ domain. The BTB/POZ domain mediates homomeric and heteromeric POZ-POZ interactions and is common to transcriptional regulators involved in chromatin modeling. In several BTB/POZ containing proteins, including BCL-6 and the promyelocytic leukemia zinc-finger (PLZF) oncoprotein, this domain interacts with the SMRT/N-CoR-mSin3A HDAC complex and is directly involved in repressing and silencing gene transcription. When this domain is deleted, as with the oncogenic PLZF-RAR chimera of promyelocytic leukemias, this transcriptional repression is attenuated. This suggests that BTBD14A may play a role in transcription regulation.
Also known as:
BTB (POZ) domain containing 14A;Anti-?BTBD14A抗體 BTB domain containing 14A; BTB/POZ domain containing protein 14A; BTB/POZ domain-containing protein 14A; BTBD 14A; BTBD14; NAC-2; NACC2; NACC2_HUMAN; Nucleus accumbens-associated protein 2.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Anti-?BTBD14A抗體Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BTBD14A..
●
Predicted Molecular Weight: 63kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 Anti-?BTBD14A抗體 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl050Ca01 高遷移率族AT Hook蛋白1(HMGA1)多克隆抗體 Polyclonal Antibody to High Mobility Group AT Hook Protein 1 (HMGA1)
kl050Hu01 高遷移率族AT Hook蛋白1(HMGA1)多克隆抗體 Polyclonal Antibody to High Mobility Group AT Hook Protein 1 (HMGA1)
kl053Hu01 高遷移率族AT Hook蛋白2(HMGA2)多克隆抗體 Polyclonal Antibody to High Mobility Group AT Hook Protein 2 (HMGA2)
kl054Hu01 S100鈣結(jié)合蛋白P(S100P)多克隆抗體 Polyclonal Antibody to S100 Calcium Binding Protein P (S100P)
kl056Hu01 基質(zhì)金屬蛋白酶14(MMP14)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14)
kl056Mu01 基質(zhì)金屬蛋白酶14(MMP14)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14)
kl057Hu01 核因子κB受體激活因子(RANκ)多克隆抗體 Polyclonal Antibody to Receptor Activator Of Nuclear Factor Kappa B (RANk)
kl057Ra01 核因子κB受體激活因子(RANκ)多克隆抗體 Polyclonal Antibody to Receptor Activator Of Nuclear Factor Kappa B (RANk)
kl058Hu01 白介素20(IL20)多克隆抗體 Polyclonal Antibody to Interleukin 20 (IL20)
kl060Hu01 血小板衍生生長(zhǎng)因子受體α(PDGFRα)多克隆抗體 Polyclonal Antibody to Platelet Derived Growth Factor Receptor Alpha (PDGFRa)
kl060Ra01 血小板衍生生長(zhǎng)因子受體α(PDGFRα)多克隆抗體 Polyclonal Antibody to Platelet Derived Growth Factor Receptor Alpha (PDGFRa)
kl061Hu01 血小板衍生生長(zhǎng)因子受體β(PDGFRβ)多克隆抗體 Polyclonal Antibody to Platelet Derived Growth Factor Receptor Beta (PDGFRb)
kl064Hu01 白介素24(IL24)多克隆抗體 Polyclonal Antibody to Interleukin 24 (IL24)
kl064Mu01 白介素24(IL24)多克隆抗體 Polyclonal Antibody to Interleukin 24 (IL24)
